RecruitingNot ApplicableNCT05704842

Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy

Pilot Study to Evaluate the Impact of a Home-Based Exercise Program on Cancer-Related Fatigue in Breast Cancer Patients Undergoing Curative-Intent Chemotherapy


Sponsor

Virtua Health, Inc.

Enrollment

40 participants

Start Date

Dec 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Assess feasibility of home exercise in reducing fatigue in subjects with breast cancer receiving curative intent chemotherapy. Subjects are randomized to control (no exercise) or intervention group (exercise). The PRO-CTCAE tool and FACIT Fatigue Scale are used to collect patient reported outcomes. Subjects submit data via mobile phone, tablet or computer. Assessments are weekly during chemotherapy (10-20 wks), at end of chemotherapy and 1, 3 and 6 months after chemotherapy.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria8

  • Women with curative-intent breast cancer who plan to undergo at least 4 cycles of chemotherapy.
  • Age \> 18 years
  • ECOG performance score \< 3
  • English-speaking
  • with sufficient vision/hearing or family support
  • Coronary artery disease, if cleared by cardiologist
  • Subject must have smart phone, computer or tablet.
  • Willingness to be randomized

Exclusion Criteria5

  • Medical or psychiatric conditions (beyond those related to breast cancer and its treatment) that would impair our ability to test study hypotheses (psychotic disorders, dementia, inability to give informed consent or follow instructions).
  • Patients with overt evidence of a psychiatric disorder.
  • Coronary artery disease, not cleared by cardiologist.
  • Contraindication to exercise.
  • Chronic fatigue syndrome.

Interventions

BEHAVIORALExercise

Home-based exercise program including core exercises as follows: Core Stabilization, core extension, leg extensions, squats with and without weights, shoulder and arm exercises.


Locations(1)

Virtua Health

Voorhees Township, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05704842


Related Trials